Trilantic Capital Partners has completed the sale of its stake in Fortitech to Royal DSM (NYSE: DSM KON). The all-cash transaction puts the company's total enterprise value at $634 million. Fortitech makes ingredient blends for the food and beverage, infant nutrition and dietary supplements industries, and had been a portfolio company of Trilantic since October 2010. The PE firm helped expand Fortitech's global footprint, which now includes production sites in New York, California, Brazil, Malaysia, Denmark and Poland, with additional sales offices in China, Russia and Mexico. New York-headquartered Trilantic makes control and significant minority investments in North American and European companies, with a focus on the consumer, energy, financial and business services sectors.